针对软组织肉瘤 (和其他固体瘤) 的MDM2:复苏?
Antoine Italiano1,2,3
1Early Phase Trials and Sarcoma Unit, Institut Bergonié, Bordeaux, France.
Cancer discovery
|August 4, 2023
概括
鼠类双分钟2 (MDM2) 抑制剂提供了一种针对p53的新方法,用于固体瘤,特别是肉瘤. 早期研究表明,MDM2-p53对抗剂在治疗这些具有挑战性的癌症方面具有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 在癌症中,p53瘤抑制途径经常被禁用.
- 在某些固体瘤,特别是肉瘤中,MDM2基因的放大是常见的.
- MDM2 抑制剂为具有野生类型p53.3的瘤提供了向治疗策略.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
7.2K
相关概念视频
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K